US Specialty: 2020 Patient Choice Award Finalist

For the fourth year in a row, US Specialty Care, the specialty pharmacy owned and operated by WellDyne, has been honored as a finalist in the annual Patient Choice Awards, PBM/payer specialty pharmacy category. Presented by MMIT and Zitter Insights, the award recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall care, measured by patient satisfaction ratings in the ZHI Specialty Pharmacy Patient Satisfaction Survey.

“This award recognizes our commitment and affirms that our high-touch, personalized approach is working well,” says Michael Arnold, Director of Specialty Operations. “For patients with complex, chronic conditions, medication adherence is key to helping them stay healthy. Our specialty pharmacy team is dedicated to helping patients engage in their health which in turn leads to higher adherence and better health outcomes.”

US Specialty recognizes that each individual brings a unique history, experience and perspective in making healthcare choices. Focusing on the person, US Specialty Care treats every patient in a holistic manner based on that individual’s specific circumstances. Using a patient-centric approach to deliver high-touch and high-tech support, US Specialty achieved industry-leading levels of medication adherence – 93.5% overall in 2019. “We offer a variety of options so patients can choose their preferred method to connect,” says Michael. Whether it’s via phone, video chat or text, US Specialty supports patients on their individual health journey.

In 2017, US Specialty won the inaugural Patient Choice Award and subsequently achieved finalist status in both 2018 and 2019. The award represents the highest quality in customer service and optimal patient care by a specialty pharmacy.